Neogen (NEOG) closed at $11.68 on Oct 7, 2026, down 2.3% on the day. The stock is down 1.8% over the past month, up 19.8% over three months, up 67.1% year to date and up 107.5% over the past year. It trades 18.1% below its 52-week high of $14.26 and 117.5% above its 52-week low of $5.37. The close sits below its 50-day moving average ($12.07) and above its 200-day moving average ($10.07).
Over its last 8 reports the stock moved an average of 15.1% on the first trading day after earnings, beating the options-implied move in 4 of 8.
Short interest was 6.8% of float (5.7 days to cover) as of Sep 15, 2026.
Over the last 8 reports, NEOG moved an average of 15.1% on the first trading day after earnings. The move beat the options-implied move in 4 of 8 reports.
Yes — the Oct 7, 2026 close of $11.68 is 16.0% above the 200-day average of $10.07.
NEOG closed 18.1% below its 52-week high of $14.26.
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
